Literature DB >> 30882175

Potential Prognostic Role for SPOP, DAXX, RARRES1, and LAMP2 as an Autophagy Related Genes in Prostate Cancer.

Leila Jamali1, Afshin Moradi2, Maziar Ganji1, Mohsen Ayati3, Behrang Kazeminezhad4, Zahra Fazeli Attar1, Hamid Ghaedi1, Seyyed Mohammad Hossein Ghaderian5, Morteza Fallah-Karkan6, Arash Ranjbar6.   

Abstract

PURPOSE: Autophagy plays a critical role in PCa development. DAXX has a potent pro-survival effect by enhancing cell growth in PCa via suppression of autophagy. Here, we depicted a network governed by DAXX and SPOP by which the autophagy pathway is suppressed through the ubiquitination and modulation of key cellular signaling pathways mediators including LAMP2 and RARRES1.
MATERIALS AND METHODS: Through network-based bioinformatics approaches, the expression levels of DAXX, RARRES1, LAMP2, and SPOP genes was assessed in 50 PCa tissues and 50 normal adjacent from the same sample as well as 50 benign prostatic hyperplasia (BPH) tissues by quantitative RT-PCR. The normal adjacent tissues were taken from regions more than 5mm away from the bulk of those tumor tissues with clearly distinct margins. RNA extraction, cDNA synthesis and Real-time Quantitative RT-PCR were done for assessment of gene expression. To evaluate the primary gene network centered on autophagy pathway, according to the Query-dependent weighting algorithm, these two networks were integrated with Cytoscape 3.4 software.
RESULTS: We found that in PCa tissues the DAXX expression level was significantly increased (P < 0.001) and the expressions of SPOP, RARRES1, and LAMP2 were significantly down-regulated, when compared to both control groups including normal adjacent and BPH tissues. Moreover, significant correlations were observed between expression levels of all four genes. Additionally, ROC curve analysis revealed that LAMP2 had the most sensitivity and specificity.
CONCLUSION: These findings suggest that the contribution of SPOP, DAXX, RARRES1, and LAMP2 together could be a putative regulatory element acting as a prognostic signature and therapeutic target in PCa.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 30882175     DOI: 10.22037/uj.v0i0.4935

Source DB:  PubMed          Journal:  Urol J        ISSN: 1735-1308            Impact factor:   1.510


  5 in total

1.  The Role of Lysosome-associated Membrane Protein 2 in Prostate Cancer Chemopreventive Mechanisms of Sulforaphane.

Authors:  Eun-Ryeong Hahm; Krishna B Singh; Su-Hyeong Kim; Anna A Powolny; Shivendra V Singh
Journal:  Cancer Prev Res (Phila)       Date:  2020-05-20

2.  Identification and functional analysis of LncRNA-XIST ceRNA network in prostate cancer.

Authors:  Jie Wang; Jie Huang; Yingxue Guo; Yuli Fu; Yifang Cao; Kang Zhou; Jianxiong Ma; Bodong Lv; Wenjie Huang
Journal:  BMC Cancer       Date:  2022-08-29       Impact factor: 4.638

3.  LAMP2 as a Biomarker Related to Prognosis and Immune Infiltration in Esophageal Cancer and Other Cancers: A Comprehensive Pan-Cancer Analysis.

Authors:  Shan-Peng Liu; Xiao-Min Li; Dan-Man Liu; Shu-Huan Xie; Shao-Bo Zhang; Yu Li; Ze-Feng Xie
Journal:  Front Oncol       Date:  2022-04-21       Impact factor: 5.738

Review 4.  Targeting Cytoprotective Autophagy to Enhance Anticancer Therapies.

Authors:  Malina Xiao; Alice Benoit; Meriem Hasmim; Caroline Duhem; Guillaume Vogin; Guy Berchem; Muhammad Zaeem Noman; Bassam Janji
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

Review 5.  Dynamic Activity of Histone H3-Specific Chaperone Complexes in Oncogenesis.

Authors:  Ting Wen; Qiao Yi Chen
Journal:  Front Oncol       Date:  2022-01-11       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.